An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

One man’s fascination with malaria helps fuel the search for new treatments.